Proteomics Discovery of Disease Biomarkers

被引:0
|
作者
Ahram, Mamoun [1 ]
Petricoin, Emanuel F. [2 ]
机构
[1] Mutah Univ, Dept Physiol & Pharmacol, Fac Med, Mutah, Jordan
[2] George Mason Univ, Ctr Appl Prote & Mol Med, Fairfax, VA 22030 USA
来源
BIOMARKER INSIGHTS | 2008年 / 3卷
关键词
proteomics; mass spectrometry; protein microarrays; surface enhanced laser desorption/ionization; bioinformatics;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Recent technological developments in proteomics have shown promising initiatives in identifying novel biomarkers of various diseases. Such technologies are capable of investigating multiple samples and generating large amount of data end-points. Examples of two promising proteomics technologies are mass spectrometry, including an instrument based on surface enhanced laser desorption/ionization, and protein microarrays. Proteomics data must, however, undergo analytical processing using bioinformatics. Due to limitations in proteomics tools including shortcomings in bioinformatics analysis, predictive bioinformatics can be utilized as an alternative strategy prior to performing elaborate, high-throughput proteomics procedures. This review describes mass spectrometry, protein microarrays, and bioinformatics and their roles in biomarker discovery, and highlights the significance of integration between proteomics and bioinformatics.
引用
收藏
页码:325 / 333
页数:9
相关论文
共 50 条
  • [21] The biomarkers discovery of hyperuricemia and gout: proteomics and metabolomics
    Wu, Xinghong
    You, Chongge
    [J]. PEERJ, 2023, 11
  • [22] Proteomics in Cancer Biomarkers Discovery: Challenges and Applications
    Sallam, Reem M.
    [J]. DISEASE MARKERS, 2015, 2015 : 1 - 12
  • [23] Application of Proteomics in the Discovery of Radiosensitive Cancer Biomarkers
    Luo, Hui
    Ge, Hong
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [24] Platelets in Healthy and Disease States: From Biomarkers Discovery to Drug Targets Identification by Proteomics
    Gianazza, Erica
    Brioschi, Maura
    Baetta, Roberta
    Mallia, Alice
    Banfi, Cristina
    Tremoli, Elena
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) : 1 - 44
  • [25] PROTEOMICS DISCOVERY OF BIOMARKERS IN STATIN-TREATED PATIENTS WITH ADVANCED CORONARY ARTERY DISEASE
    Tzani, Aspasia
    Doulamis, Ilias
    Konstantopoulos, Panagiotis
    Antoranz, Asier
    Pliaka, Vaia
    Minia, Aggeliki
    Gkogkos, Anastasios
    Samanidis, George
    Sakellaropoulos, Theodore
    Alexopoulos, Leonidas
    Perrea, Despina
    Perreas, Konstantinos
    [J]. ATHEROSCLEROSIS, 2017, 263 : E241 - E241
  • [26] Proximal fluid proteomics for the discovery of digestive cancer biomarkers
    Farina, Annarita
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2014, 1844 (05): : 988 - 1002
  • [27] Discovery of biomarkers of redox changes in vivo using proteomics
    Griffiths, H.
    [J]. FREE RADICAL RESEARCH, 2008, 42 : S47 - S47
  • [28] DISCOVERY AND VERIFICATION OF AMYOTROPHIC LATERAL SCLEROSIS BIOMARKERS BY PROTEOMICS
    Ryberg, Henrik
    An, Jiyan
    Darko, Samuel
    Lustgarten, Jonathan Llyle
    Jaffa, Matt
    Gopalakrishnan, Vanathi
    Lacomis, David
    Cudkowicz, Merit
    Bowser, Robert
    [J]. MUSCLE & NERVE, 2010, 42 (01) : 104 - 111
  • [29] Biomarkers discovery; a proteomics approach for brain cancer profiling
    Khalil, A. A.
    Krogh, M.
    Salford, L.
    James, P.
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2005, 4 (08) : S114 - S114
  • [30] Proteomics discovery of chemoresistant biomarkers for ovarian cancer therapy
    Deng, Junli
    Wang, Li
    Ni, Jie
    Beretov, Julia
    Wasinger, Valerie
    Wu, Duojia
    Duan, Wei
    Graham, Peter
    Li, Yong
    [J]. EXPERT REVIEW OF PROTEOMICS, 2016, 13 (10) : 905 - 915